Everyone sweats. Whether it is breaking a sweat at the gym or walking to work on a hot day, perspiration is the body’s natural cooling mechanism. But for about 5% of the population, sweating can be abnormal, excessive and uncontrollable.
That’s due to a rare condition called hyperhidrosis.
Health insurers and pharmacy benefit managers are not making the grade when it comes to access to medications for autoimmune diseases, according to a new study. But insurers say the study doesn't paint the full picture.
If you live in Philadelphia, you may wait 78 days. In Cedar Rapids, 91 days. According to a new report, long waits for dermatology appointments – for both new and returning patients – have become the norm. And that’s a problem.
Click below to read brochure.
Paul has been coming to our dermatology office for years. He has painful psoriasis; after years of trying different medications he finally found one that controls his symptoms. Then Paul changed insurance companies in the middle of his treatment.
Skin conditions affect tens of millions of people across the United States with symptoms that range from purely cosmetic to downright painful—and in some cases lethal. In addition, skin conditions can signal deeper problems.
Devastating. Awful. Miserable. That’s how patients and advocates described step therapy during a recent Derma Care Access Network policy panel on Capitol Hill.
There's a treatment on the rise in the medical industry. It's called Biologics, and it's helping treat severe eczema and asthma.
Let me share the story of one of my patients who suffers from severe eczema.
DCAN member National Alopecia Areata Foundation is hosting a Super Power Challenge for Alopecia Areata Awareness Month.
The Eczema Exposed YouTube channel has a number of videos that can serve as a resource for patients who have eczema.
As a result, your insurer may not cover certain treatments prescribed to you or may require you to take a number of steps before your treatment is approved.
Learn more here.
After spending time and money to see a dermatologist, many patients with acne fail to fill their prescription. Cost sharing is the culprit, according to a recently published study.
Data published in the Journal of Rheumatology revealed that 27% of patients with psoriatic arthritis who had experience with biologics and/or small-molecule agents reported barriers to treatment, with the most common hurdles being coverage ineligibility and high out-of-pocket costs.
Atopic dermatitis (AD) is a common, chronic, relapsing, inflammatory skin disease that affects children and adults. Until recently, the only Food and Drug Administration–approved systemic treatment option for patients with moderate-to-severe AD was systemic steroids, which are not recommended by current guidelines and are commonly associated with disease rebound.
